Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

First-line Gefitinib Versus Chemotherapy for Lung Adenocarcinoma in Never Smoker

This study has been completed.
Sponsor:
Collaborator:
AstraZeneca
Information provided by:
National Cancer Center, Korea
ClinicalTrials.gov Identifier:
NCT00455936
First received: April 3, 2007
Last updated: October 22, 2010
Last verified: March 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2010
  Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)
No publications provided by National Cancer Center, Korea

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):